Health Care & Life Sciences » Pharmaceuticals | Shanghai Shyndec Pharmaceutical Co. Ltd.

Shanghai Shyndec Pharmaceutical Co. Ltd. A | Cash Flow

Fiscal year is January-December. All values CNY Millions.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
188
248
292
854
819
1,070
Depreciation, Depletion & Amortization
75
105
161
727
784
731
Other Funds
105
117
134
649
275
116
Funds from Operations
286
427
579
1,846
1,809
1,633
Changes in Working Capital
78
168
344
1,001
506
36
Net Operating Cash Flow
207
259
234
845
2,315
1,669
Capital Expenditures
513
431
235
241
168
Sale of Fixed Assets & Businesses
9
9
4
15
19
Purchase/Sale of Investments
-
-
4
74
4
Net Investing Cash Flow
581
722
243
63
204
Cash Dividends Paid - Total
-
-
58
14
144
Issuance/Reduction of Debt, Net
449
555
217
395
891
Net Financing Cash Flow
344
438
25
269
1,310
Net Change in Cash
31
25
18
516
797
Free Cash Flow
305
172
-
604
2,146
Deferred Taxes & Investment Tax Credit
20
9
5
24
42
51
Net Assets from Acquisitions
78
300
9
-
65
Other Sources
1
-
-
312
26
Exchange Rate Effect
1
-
1
2
4
Other Uses
-
-
-
75
12

About Shanghai Shyndec Pharmaceutical Co.

View Profile
Address
1320 Beijing West Road
Shanghai Shanghai 200040
China
Employees -
Website http://www.shyndec.com
Updated 07/08/2019
Shanghai Shyndec Pharmaceutical Co., Ltd. principally engages in the research, development, manufacturing, and sale of pharmaceutical products. Its product range covers anti-infective drugs, cardiovascular and cerebrovascular drugs, anti-tumour drugs, anaesthetic psychotropic drugs, as well as metabolic and endocrine drugs. The company was founded in 1996 and is headquartered in Shanghai, China.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.